Overview Rating

Speculative

Technicals Analysis

100

0100

Financials Analysis

0100

AbbVie Stock (NYSE:ABBV), Quotes and News Summary

Q: What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.

Open	$160.805
Close	-
Volume / Avg.	1.339M / 5.692M
Day Range	160.020 - 161.320
52 Wk Range	130.960 - 182.890
Market Cap	$283.590B
P/E Ratio	47.753
Dividend Yield	3.860%
Exchange	NYSE
RSI	38
Short Interest	0.77%
Days to Cover	2.43

Recent News

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

The first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned.

Zacks

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Shanthi Rexaline

Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost

Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of $3,500 yearly.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy AbbVie (ABBV) stock?

You can purchase shares of AbbVie (NYSE: ABBV) through any online brokerage.

View our list of the best stock brokerages.

Who are AbbVie's (ABBV) competitors?

Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for AbbVie (ABBV) stock?

The latest price target for AbbVie (NYSE: ABBV) was reported by Barclays on Monday, April 29, 2024. The analyst firm set a price target for 187.00 expecting ABBV to rise to within 12 months (a possible 16.44% upside). 23 analyst firms have reported ratings in the last year.

Current Stock Price for AbbVie (ABBV)?

The stock price for AbbVie (NYSE: ABBV) is $160.595 last updated Today at May 9, 2024 at 1:46 PM EDT.

Does AbbVie (ABBV) pay a dividend?

A quarterly cash dividend of $1.55 per share of Class A Common Stock. The quarterly cash dividend was payable on May 15, 2024 to stockholders of record on April 12, 2024.

When is AbbVie (NYSE:ABBV) reporting earnings?

AbbVie’s Q2 earnings are confirmed for Thursday, July 25, 2024.

Is AbbVie (ABBV) going to split?

There is no upcoming split for AbbVie.

What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-